Intelligence · Clinical pipeline
Infectious disease · Approved programs
Infectious disease programs at Approved programs — ClinicalTrials.gov pipeline intelligence.
Quick answer
Infectious disease Approved programs programs: NovaPharmaNews indexes 151 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Chinese Academy of 28 programs
- Sinovac Research and 20 programs
- United Therapeutics Europe 15 programs
- BRIGHT MINDS BIOSCIENCES 14 programs
- George Institute for 13 programs
- First People's Hospital 11 programs
- Hospital Authority 7 programs
- Disc Medicine 4 programs
- GSK Glaxo Smith 4 programs
- Anaxis Pharma 2 programs
- HOFFMANN-LA ROCHE 2 programs
- Phathom Pharmaceuticals 2 programs
Pipeline programs
-
-
The George Institute
Acute lower Respiratory Tract Infection or acute rhinosinusitis
1 trial -
103900
Disc Medicine
HIV-infected
1 trial -
112771
Disc Medicine
Fungal infection
1 trial -
2 doses of HAV
Sinovac Research and Development Co.,
Hepatitis A
1 trial -
201010025M
Hospital Authority, Hong Kong
Hepatitis
1 trial -
2018ZX10721202001002001
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B Vaccine
3 trials -
219815
GlaxoSmithKline
Respiratory Syncytial Virus Infections
1 trial -
60 µg dose hepatitis B vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B Vaccine
1 trial -
60 µg dose hepatitis B vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B Vaccination
1 trial -
AB.OH.2025
The George Institute
Infectious diseases
1 trial -
AL (Coartem)
United Therapeutics Europe Ltd
Malaria
1 trial -
AMOXICILINA NORMON 1000 mg Comprimidos EFG
The George Institute
Infective endocarditis
1 trial -
AZD1222
AstraZeneca
COVID-19, SARS-CoV-2
1 trial -
Adefovir
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B, Chronic
1 trial -
Adult group in immunogenicity and safety study of combined immunization
Sinovac Research and Development Co.,
COVID-19
1 trial -
Aerosolized 13 cis retinoic acid plus Vitamin D
The First People's Hospital of Lianyungang
Post COVID-19 Anosmia (Loss of Smell)
1 trial -
Algorithm Treatment
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
Amodiaquine plus Artesunate co-administration
United Therapeutics Europe Ltd
Malaria
1 trial -
Amoxicillin/clavulanate
GlaxoSmithKline
Focal Infection, Dental
1 trial -
Ampicillin
Takeda
Surgical Site Infection
1 trial -
Antiretroviral therapy (ART)
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Artemether-lumefantrine combination
United Therapeutics Europe Ltd
Plasmodium Vivax Infection
1 trial -
Artesunate-amodiaquine combination
United Therapeutics Europe Ltd
Malaria,Falciparum
1 trial -
Athena strategy
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
Azvudine
The First People's Hospital of Lianyungang
COVID-19
1 trial -
BIMERVAX LP.8.1 emulsion for injection COVID... for COVID-19 infection
The George Institute
COVID-19 infection
1 trial -
BV-2020/08
Lacuna Pharma Pty Ltd
Respiratory Tract Infections with Wheezing Lower Respiratory Illness
1 trial -
Biktarvy 50 mg/200 mg/25 mg film-coated tablets
Gilead Sciences Pty Limited
HIV-1 infection
1 trial -
CEFAZOLIN
Pari Pharma GmbH
Infection prophylaxis
1 trial -
CEFOSPROST
The George Institute
Acute bacterial prostatitis
1 trial -
COVAX
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
1 trial -
COVID-19 Vaccine (Vero cell), Inactivated
Sinovac Research and Development Co.,
COVID-19
1 trial -
Ceftriaxon Fresenius Kabi poeder voor oplossi... for Sepsis
Disc Medicine
Sepsis
1 trial -
Chlorhexidine
CRESCENT BIOPHARMA, INC.
Neonatal Infections
1 trial -
Chloroquine
United Therapeutics Europe Ltd
Malaria, Falciparum
1 trial -
Ciprofloxacin
Iterum Therapeutics plc
UTI - Lower Urinary Tract Infection
1 trial -
Citrate anticoagulation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
Coartem™ (Artemether-lumefantrine combination)
United Therapeutics Europe Ltd
Malaria
1 trial -
Covid-19 vaccine (0-1-4 schedule)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
2 trials -
DAN-COVID
Moderna Biotech Spain
SARS-CoV-2 infection
1 trial -
DAN-RSV
Pfizer Australia Pty Ltd
RSV-infection
1 trial -
Depo-Medroxyprogesterone Acetate
United Therapeutics Europe Ltd
HIV
1 trial -
ETHINYL ESTRADIOL AND LEVOGESTREL
United Therapeutics Europe Ltd
HIV/AIDS
1 trial -
Engerix-B 20 mcg
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Engerix™ -B
GlaxoSmithKline
Hepatitis B
1 trial -
Entecavir + Placebo
ShuGuang Hospital
Liver Cirrhosis Due to Hepatitis B Virus
1 trial -
Entecavir+Fuzheng Huayu+TCM Granule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B Virus Related Cirrhosis
1 trial -
Entecavir, Adefovir
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial
Frequently asked questions
How many infectious disease Approved programs programs exist?
151 programs match both the therapeutic area and stage filters in our published index.